The occurrence of acute myocardial infarction in Italy: A five-year analysis of hospital discharge records

Aging Clinical and Experimental Research

Volumn 23, Issue 1, 2011, Pages 49-54

  Piscitelli, Prisco ^a,b   Iolascon, Giovanni ^c   Greco, Marco ^a   Marinelli, Alessandra ^c   Gimigliano, Francesca ^c   Gimigliano, Raffaele ^c   Gisonni, Pietro ^d   Giordano, Antonio ^e   Migliore, Alberto ^f   Granata, Mauro ^g   Tarantino, Umberto ^h   Brandi, Maria Luisa ^b   Baggiani, Angelo ⁱ   Distante, Alessandro ^a,i  

^a C/o ISBEM Research Center ^*  (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^e Human Health Foundation   (Italy)

^f FATEBENEFRATELLI HOSPITAL   (Italy)

^g SAN FILIPPO NERI HOSPITAL   (Italy)

^h UNIVERSITY OF ROME TOR VERGATA   (Italy)

ⁱ UNIVERSITY OF PISA   (Italy)

Author keywords

AMI; Costs; Hospitalizations; Rehabilitation

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOPLASTY; ARTICLE; CORONARY ARTERY BYPASS SURGERY; DATA BASE; EVALUATION; FEMALE; GROUPS BY AGE; HOSPITAL ADMISSION; HOSPITAL COST; HOSPITAL DISCHARGE; HUMAN; INCIDENCE; ITALY; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; REGISTRATION; REHABILITATION CARE; SEX RATIO;

EID: 79956311568     PISSN: 15940667     EISSN: 17208319     Source Type: Journal    
DOI: 10.1007/BF03337744     Document Type: Article

References (33)

1. National Statistics Report 2002. Italian Institute for Statistics, Rome.
2. Italian Senate Health Commission (2002) Official Report of the Survey on Osteoporosis. Italian Senate, Rome.
3. Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol 1957; 2: 298-300.
4. Farber JL, Kyle ME, Coleman JB. Mechanisms of cell injury by activated oxygen species. Lab Invest 1990; 62: 670-9. (Pubitemid 20213684)
5. Lawrence T, Willoughby DA, Gilroy DW. Anti-inflammatory lipid mediators and insights into the resolution of inflammation. Nat Rev Immunol 2002; 2: 787-95. (Pubitemid 37328718)
6. Larsen GL, Henson PM. Mediators of inflammation. Annu Rev Immunol 1983; 1: 335-59.
7. Shanley TP, Warner RL, Ward PA. The role of cytokines and adhesion molecules in the development of inflammatory injury. Mol Med Today 1995; 1: 40-5.
8. De Martinis M, Franceschi C, Monti D, Ginaldi L. Inflamm-ageing and lifelong antigenic load as major determinants of ageing rate and longevity. FEBS Lett 2005; 579: 2035-9. (Pubitemid 40469666)
9. Finch CE, Crimmins EM. Inflammatory exposure and historical changes in human life-spans. Science 2004; 305: 1736-9. (Pubitemid 39249633)
10. Bruunsgaard H, Pedersen M, Pedersen BK. Aging and proinflammatory cytokines. Curr Opin Hematol 2001; 8: 131-6.
11. Eckel RH, Kahn R, Robertson RM, Rizza RA. Preventing cardiovascular disease and diabetes: a call to action from the American Diabetes Association and the American Heart Association. Circulation 2006; 113: 2943-6. (Pubitemid 44297236)
12. Poirier P, Giles TD, Bray GA et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss. Circulation 2006; 113: 898-918.
13. The American Heart Association. American heart association updates recommendations for blood pressure measurements. Hypertension 2005; 45: 2-21.
14. Grundy SM, Cleeman JI, Bairey Merz CN et al. Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines. Circulation 2004; 110: 227-39. (Pubitemid 38924592)
15. Pearson TA. American Heart Association Guide for Improving Cardiovascular Health at the Community Level. Circulation 2003; 107: 645.
16. Herlitz J, Karlson BW, Hjamarson A. Mortality and morbidity during one year of follow-up in suspected acute myocardial infarction in relation to early diagnosis: experiences from the MIAMI trial. J Intern Med 1990; 228: 125-31. (Pubitemid 20257278)
17. Dickstein K, Snappin S. Prediction of morbidity and mortality following myocardial infarction. J Am Coll Cardiol 2002; 39 (Suppl 1): 194.
18. Elizari MV, Martinez JM, Belziti C et al. Morbidity and mortality following early administration of amiodarone in acute myocardial infarction. Eur Heart J 2000; 21: 198-205. (Pubitemid 30137804)
19. Vaccarino V, Krumholz HM, Berkman LF, Horwitz RI. Sex-based differences in early mortality after myocardial infarction. N Engl J Med 1999; 341: 217-25. (Pubitemid 29334519)
20. Tu JV. Introduction to the Canadian Cardiovascular Outcomes Research Team's (CCORT) Canadian Cardiovascular Atlas project. Can J Cardiol 2003; 19: 225-9. (Pubitemid 36603442)
21. Thom T, Haase N, Rosamond W et al. A report from the American Heart Association statistics committee and stroke statistics subcommittee. Circulation 2006; 113: e85.
22. Tunstall-Pedoe H, Kuulasmaa K, Mähönen M, Tolonen H, Ruokokoski E, Amouyel P. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease. Lancet 1999; 353: 1547-57. (Pubitemid 29219203)
23. Ferrario MM, Fornari C, Bolognesi L. Recent time trends of myocardial infarction rates in northern Italy. Results from the MONICA and CAMUNI registries in Brianza: 1993-1994 versus 1997-1998. Ital Heart J 2003; 4 (Suppl): 651-7.
24. Ferrario M, Cesana G, Vanuzzo D et al. Surveillance of ischaemic heart disease: results from the Italian MONICA populations. Int J Epidemiol 2001; (Suppl 1): S23-9
25. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, Pajak A. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 1994; 90: 583-612.
26. Tiemann O. Variations in hospitalisation costs for acute myocardial infarction: a comparison across Europe. Health Econ 2008; 17: S33-45.
27. Piscitelli P, Iolascon G, Gimigliano F. Incidence and costs of hip fractures vs. acute myocardial infarction in the Italian population: a 4-year survey. Osteoporos Int 2007; 18: 211-9. (Pubitemid 46090225)
28. Jonsson B, Buxton M, Kahan T, Poulter NR, Svarvar P, Anglo-Scandinavian Cardiac Outcomes Trial, Health Economic Working Group. The effects of cardiac events on quality of life and indirect costs. J Hum Hypertens 2001; 15 (Suppl 1): S91-3.
29. Preventing chronic diseases: a vital investment. WHO Global Report, Geneva, 2005.
30. Etemad LR, McCollam PL. Total first-year costs of acute coronary syndrome in a managed care setting. J Manag Care Pharm 2005; 4: 300-6.
31. Zethraeus N, Molin T, Henriksson P, Jonsson B. Costs of coronary heart disease and stroke: the case of Sweden. J Intern Med 1999; 246: 151-9. (Pubitemid 29378920)
32. Eisenstein EL, Shaw LK, Anstrom KJ et al. Assessing the clinical and economic burden of coronary artery disease: 1986-1998. Med Care 2001; 39: 824-35.
33. Turpie AG. Burden of disease: medical and economic impact of coronary syndromes. Am J Manag Care 2006; 16 (Suppl): S430-4.